Arbutus Biopharma Corporation

ABUSNASDAQHealthcare● Active

$4.24

$-0.01(-0.24%)

Market Cap$837559890

P/E Ratio—

52W High$5.1

52W Low$3.04

Avg Volume1.9M

Open$4.30

Beta0.63

Net Income Financials Revenue

Arbutus Biopharma Corporation (ABUS) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

ABUS · net income · updated Jun 8, 2026

Core profitability metrics

ABUS · net income · margin · TTM · CAGR

Net income was −$33.5M for FY2025 (fiscal year ending 2025-12-31), up 52.1% year-over-year. Net profit margin was -237.9%. Based on available data, Arbutus Biopharma Corporation has been profitable since at least 2012.

FY2025 Net Income−$33.5M▲ +52.1% YoY

Trailing 12M (TTM)$160.7Mtrailing 4 quarters sum

Net Profit Margin-237.9%−$33.5M ÷ $14.1M

YoY Change+52.1%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2012

▸ FMP /income-statement · Annual · ABUS net income history · ABUS profit margin

Annual net income data

ABUS · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$33.5M▲ +52.1%-237.9%$14.1M

FY2024Loss−$69.9M▲ +4.0%-1133.0%$6.2M

FY2023Loss−$72.8M▼ 4.9%-401.6%$18.1M

FY2022Loss−$69.5M▲ +8.9%-178.0%$39.0M

FY2021Loss−$76.2M▼ 19.6%-693.9%$11.0M

Net income vs peers (Healthcare)

ABUS vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Arbutus Biopharma CorporationYOU

ABUS

−$33.5M+52.1%-237.9%

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Arbutus Biopharma Corporation (ABUS) reported net income of −$33.5M for FY2025 (fiscal year ending 2025-12-31), up 52.1% year-over-year. The net profit margin was -237.9% — meaning the company kept $-2.38 of every dollar of revenue as profit.

Based on available data, Arbutus Biopharma Corporation has been profitable since at least 2012. Net income reached a peak of $29.9M in FY2012. Data available for 15 fiscal years.

Arbutus Biopharma Corporation's net profit margin was -237.9% for FY2025, based on the latest annual results.

Investors sometimes search for "Arbutus Biopharma Corporation net worth" — the company's market capitalization is a separate figure from ABUS net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

ABUS net income · 5 questions

Arbutus Biopharma Corporation is not currently profitable on an annual basis. The company reported a net loss of $33.5M for FY2025.

is ABUS profitabledoes ABUS make a profitABUS profitabilityABUS profitable company

▸ Source: FMP /income-statement · GAAP · Arbutus Biopharma Corporation · Arbutus Biopharma Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026